Baxter

Type
Internal restructuring
Country
Austria
Region
Ostösterreich; Niederösterreich; Wiener Umland/Nordteil
Location of affected unit(s)
Orth an der Donau
Sector
Manufacturing
(20 - 21) Manufacture of chemicals and pharmaceuticals
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
100 jobs
Number of planned job losses
Job loss
Announcement Date
26 November 2013
Employment effect (start)
Foreseen end date

Description

Pharmaceutical and biotechnology company Baxter announced to reduce its workforce in Orth (Lower Austria) by 100 staff members.

This is due to a group-wide reorganisation in the wake of the acquisition of Gambro (7,000 staff) earlier this year. Within the same process, Baxter is planning to cease its operations in Bohumil (Czech Republic), making 280 workers redundant.

The company is a subsidiary of Baxter International, headquartered in the US and employing about 50,000 staff globally.

Sources

  • 27 November 2013: Die Presse
  • 26 November 2013: Der Standard

Citation

Eurofound (2013), Baxter, Internal restructuring in Austria, factsheet number 76264, European Restructuring Monitor. Dublin, https://apps.eurofound.europa.eu/restructuring-events/detail/76264.